APO Research
Talk to an analyst

APO RESEARCH · REPORT

PVA Embolization Particles

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PVA Embolization Particles Industry Growth and Trends Forecast to 2032

20 December 202590 pages

Choose your research edition.

Industry ResearchPVA Embolization Particles Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal PVA Embolization Particles Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal PVA Embolization Particles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PVA Embolization Particles Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal PVA Embolization Particles Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global PVA Embolization Particles market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PVA Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PVA Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PVA Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PVA Embolization Particles include Boston Scientific Corporation, Terumo Corporation, Sirtex Medical, Merit Medical, INterface BIOmaterials, HENGRUI Medical, Cook Medical, BTG Medical and Alicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PVA Embolization Particles market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PVA Embolization Particles market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PVA Embolization Particles market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PVA Embolization Particles.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PVA Embolization Particles market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PVA Embolization Particles Market by Company

Boston Scientific Corporation

Terumo Corporation

Sirtex Medical

Merit Medical

INterface BIOmaterials

HENGRUI Medical

Cook Medical

BTG Medical

Alicon

PVA Embolization Particles Segment by Type

Conventional/Irregular PVA

Compressible and Spherical PVA

PVA Embolization Particles Segment by Application

Trauma Embolization

Liver Tumor Embolization

Prostatic Artery Embolization

Uterine Fibroid Embolization

Other

PVA Embolization Particles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PVA Embolization Particles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PVA Embolization Particles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PVA Embolization Particles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PVA Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Conventional/Irregular PVA Table 2. Major Company of Compressible and Spherical PVA Table 3. Global PVA Embolization Particles Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 5. Global PVA Embolization Particles Sales Market Share in Volume by Type (2021-2026) Table 6. Global PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 7. Global PVA Embolization Particles Sales Market Share in Value by Type (2021-2026) Table 8. Global PVA Embolization Particles Price by Type (2021-2026) & (US$/unit) Table 9. Global PVA Embolization Particles Sales by Type (2027-2032) & (k units) Table 10. Global PVA Embolization Particles Sales Market Share in Volume by Type (2027-2032) Table 11. Global PVA Embolization Particles Sales by Type (2027-2032) & (US$ Million) Table 12. Global PVA Embolization Particles Sales Market Share in Value by Type (2027-2032) Table 13. Global PVA Embolization Particles Price by Type (2027-2032) & (US$/unit) Table 14. North America PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 15. North America PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 16. Europe PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 17. Europe PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 21. Latin America PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa PVA Embolization Particles Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa PVA Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 24. PVA Embolization Particles Industry Trends Table 25. PVA Embolization Particles Industry Drivers Table 26. PVA Embolization Particles Industry Opportunities and Challenges Table 27. PVA Embolization Particles Industry Restraints Table 28. Global PVA Embolization Particles Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global PVA Embolization Particles Revenue Market Share by Company (2021-2026) Table 30. Global PVA Embolization Particles Sales by Company (2021-2026) & (k units) Table 31. Global PVA Embolization Particles Sales Share by Company (2021-2026) Table 32. Global PVA Embolization Particles Market Price by Company (2021-2026) & (US$/unit) Table 33. Global PVA Embolization Particles Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global PVA Embolization Particles Major Company Production Sites and Headquarters Table 35. Global PVA Embolization Particles Company, Product Type & Application Table 36. Global PVA Embolization Particles Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global PVA Embolization Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global PVA Embolization Particles Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global PVA Embolization Particles Sales by Region (2021-2026) & (k units) Table 41. Global PVA Embolization Particles Sales Market Share in Volume by Region (2021-2026) Table 42. Global PVA Embolization Particles Sales by Region (2021-2026) & (US$ Million) Table 43. Global PVA Embolization Particles Sales Market Share in Value by Region (2021-2026) Table 44. Global PVA Embolization Particles Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global PVA Embolization Particles Sales by Region (2027-2032) & (k units) Table 46. Global PVA Embolization Particles Sales Market Share in Volume by Region (2027-2032) Table 47. Global PVA Embolization Particles Sales by Region (2027-2032) & (US$ Million) Table 48. Global PVA Embolization Particles Sales Market Share in Value by Region (2027-2032) Table 49. Global PVA Embolization Particles Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global PVA Embolization Particles Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 52. Global PVA Embolization Particles Sales Market Share in Volume by Application (2021-2026) Table 53. Global PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 54. Global PVA Embolization Particles Sales Market Share in Value by Application (2021-2026) Table 55. Global PVA Embolization Particles Price by Application (2021-2026) & (US$/unit) Table 56. Global PVA Embolization Particles Sales by Application (2027-2032) & (k units) Table 57. Global PVA Embolization Particles Sales Market Share in Volume by Application (2027-2032) Table 58. Global PVA Embolization Particles Sales by Application (2027-2032) & (US$ Million) Table 59. Global PVA Embolization Particles Sales Market Share in Value by Application (2027-2032) Table 60. Global PVA Embolization Particles Price by Application (2027-2032) & (US$/unit) Table 61. North America PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 62. North America PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 63. Europe PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 64. Europe PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 68. Latin America PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa PVA Embolization Particles Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa PVA Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 71. Boston Scientific Corporation Company Information Table 72. Boston Scientific Corporation Business Overview Table 73. Boston Scientific Corporation PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Boston Scientific Corporation PVA Embolization Particles Product Portfolio Table 75. Boston Scientific Corporation Recent Development Table 76. Terumo Corporation Company Information Table 77. Terumo Corporation Business Overview Table 78. Terumo Corporation PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Terumo Corporation PVA Embolization Particles Product Portfolio Table 80. Terumo Corporation Recent Development Table 81. Sirtex Medical Company Information Table 82. Sirtex Medical Business Overview Table 83. Sirtex Medical PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sirtex Medical PVA Embolization Particles Product Portfolio Table 85. Sirtex Medical Recent Development Table 86. Merit Medical Company Information Table 87. Merit Medical Business Overview Table 88. Merit Medical PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merit Medical PVA Embolization Particles Product Portfolio Table 90. Merit Medical Recent Development Table 91. INterface BIOmaterials Company Information Table 92. INterface BIOmaterials Business Overview Table 93. INterface BIOmaterials PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. INterface BIOmaterials PVA Embolization Particles Product Portfolio Table 95. INterface BIOmaterials Recent Development Table 96. HENGRUI Medical Company Information Table 97. HENGRUI Medical Business Overview Table 98. HENGRUI Medical PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. HENGRUI Medical PVA Embolization Particles Product Portfolio Table 100. HENGRUI Medical Recent Development Table 101. Cook Medical Company Information Table 102. Cook Medical Business Overview Table 103. Cook Medical PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Cook Medical PVA Embolization Particles Product Portfolio Table 105. Cook Medical Recent Development Table 106. BTG Medical Company Information Table 107. BTG Medical Business Overview Table 108. BTG Medical PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. BTG Medical PVA Embolization Particles Product Portfolio Table 110. BTG Medical Recent Development Table 111. Alicon Company Information Table 112. Alicon Business Overview Table 113. Alicon PVA Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Alicon PVA Embolization Particles Product Portfolio Table 115. Alicon Recent Development Table 116. North America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America PVA Embolization Particles Sales by Country (2021-2026) & (k units) Table 118. North America PVA Embolization Particles Sales Market Share by Country (2021-2026) Table 119. North America PVA Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 120. North America PVA Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 121. North America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America PVA Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 123. North America PVA Embolization Particles Market Share by Country (2021-2026) Table 124. North America PVA Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America PVA Embolization Particles Market Share Forecast by Country (2027-2032) Table 126. Europe PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe PVA Embolization Particles Sales by Country (2021-2026) & (k units) Table 128. Europe PVA Embolization Particles Sales Market Share by Country (2021-2026) Table 129. Europe PVA Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe PVA Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 131. Europe PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe PVA Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe PVA Embolization Particles Market Share by Country (2021-2026) Table 134. Europe PVA Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe PVA Embolization Particles Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific PVA Embolization Particles Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific PVA Embolization Particles Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific PVA Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific PVA Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific PVA Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific PVA Embolization Particles Market Share by Country (2021-2026) Table 144. Asia-Pacific PVA Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific PVA Embolization Particles Market Share Forecast by Country (2027-2032) Table 146. Latin America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America PVA Embolization Particles Sales by Country (2021-2026) & (k units) Table 148. Latin America PVA Embolization Particles Sales Market Share by Country (2021-2026) Table 149. Latin America PVA Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America PVA Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America PVA Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America PVA Embolization Particles Market Share by Country (2021-2026) Table 154. Latin America PVA Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America PVA Embolization Particles Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa PVA Embolization Particles Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa PVA Embolization Particles Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa PVA Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa PVA Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa PVA Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa PVA Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa PVA Embolization Particles Market Share by Country (2021-2026) Table 164. Middle East and Africa PVA Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa PVA Embolization Particles Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. PVA Embolization Particles Distributors List Table 169. PVA Embolization Particles Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. PVA Embolization Particles Image Figure 2. Global PVA Embolization Particles Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PVA Embolization Particles Market Size (2021-2032) & (US$ Million) Figure 4. Global PVA Embolization Particles Sales (2021-2032) & (k units) Figure 5. Conventional/Irregular PVA Image Figure 6. Global Conventional/Irregular PVA Sales YoY Growth (2021-2032) & (k units) Figure 7. Compressible and Spherical PVA Image Figure 8. Global Compressible and Spherical PVA Sales YoY Growth (2021-2032) & (k units) Figure 9. Global PVA Embolization Particles Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global PVA Embolization Particles Market Share by Type 2025 VS 2032 Figure 11. North America PVA Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 12. North America PVA Embolization Particles Sales Market Share in Value by Type in 2025 Figure 13. Europe PVA Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 14. Europe PVA Embolization Particles Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific PVA Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific PVA Embolization Particles Sales Market Share in Value by Type in 2025 Figure 17. Latin America PVA Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 18. Latin America PVA Embolization Particles Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa PVA Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa PVA Embolization Particles Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 PVA Embolization Particles Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Trauma Embolization Image Figure 24. Global Trauma Embolization Sales YoY Growth (2021-2032) & (k units) Figure 25. Liver Tumor Embolization Image Figure 26. Global Liver Tumor Embolization Sales YoY Growth (2021-2032) & (k units) Figure 27. Prostatic Artery Embolization Image Figure 28. Global Prostatic Artery Embolization Sales YoY Growth (2021-2032) & (k units) Figure 29. Uterine Fibroid Embolization Image Figure 30. Global Uterine Fibroid Embolization Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global PVA Embolization Particles Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global PVA Embolization Particles Market Share by Application 2025 VS 2032 Figure 35. North America PVA Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 36. North America PVA Embolization Particles Sales Market Share in Value by Application in 2025 Figure 37. Europe PVA Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 38. Europe PVA Embolization Particles Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific PVA Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific PVA Embolization Particles Sales Market Share in Value by Application in 2025 Figure 41. Latin America PVA Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 42. Latin America PVA Embolization Particles Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa PVA Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa PVA Embolization Particles Sales Market Share in Value by Application in 2025 Figure 45. North America PVA Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America PVA Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America PVA Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe PVA Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe PVA Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe PVA Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific PVA Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific PVA Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific PVA Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America PVA Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America PVA Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America PVA Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa PVA Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa PVA Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa PVA Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. PVA Embolization Particles Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. PVA Embolization Particles Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Conventional/Irregular PVA
  • Compressible and Spherical PVA
Applications
  • Trauma Embolization
  • Liver Tumor Embolization
  • Prostatic Artery Embolization
  • Uterine Fibroid Embolization
  • Other
Companies covered
  • Boston Scientific Corporation
  • Terumo Corporation
  • Sirtex Medical
  • Merit Medical
  • INterface BIOmaterials
  • HENGRUI Medical
  • Cook Medical
  • BTG Medical
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PVA Embolization Particles Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PVA Embolization Particles Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PVA Embolization Particles Market by Type
  6. 1.3.1 Conventional/Irregular PVA
  7. 1.3.2 Compressible and Spherical PVA
  8. 1.4 Global PVA Embolization Particles Market Size by Type
  9. 1.4.1 Global PVA Embolization Particles Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global PVA Embolization Particles Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global PVA Embolization Particles Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America PVA Embolization Particles Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe PVA Embolization Particles Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific PVA Embolization Particles Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America PVA Embolization Particles Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa PVA Embolization Particles Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PVA Embolization Particles Industry Trends
  2. 2.2 PVA Embolization Particles Industry Drivers
  3. 2.3 PVA Embolization Particles Industry Opportunities and Challenges
  4. 2.4 PVA Embolization Particles Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PVA Embolization Particles Revenue (2021-2026)
  2. 3.2 Global Top Players by PVA Embolization Particles Sales (2021-2026)
  3. 3.3 Global Top Players by PVA Embolization Particles Price (2021-2026)
  4. 3.4 Global PVA Embolization Particles Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PVA Embolization Particles Major Company Production Sites & Headquarters
  6. 3.6 Global PVA Embolization Particles Company, Product Type & Application
  7. 3.7 Global PVA Embolization Particles Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PVA Embolization Particles Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PVA Embolization Particles Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PVA Embolization Particles Tier 1, Tier 2, and Tier 3
4 PVA Embolization Particles Regional Status and Outlook
  1. 4.1 Global PVA Embolization Particles Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PVA Embolization Particles Historic Market Size by Region
  3. 4.2.1 Global PVA Embolization Particles Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PVA Embolization Particles Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PVA Embolization Particles Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PVA Embolization Particles Forecasted Market Size by Region
  7. 4.3.1 Global PVA Embolization Particles Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PVA Embolization Particles Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PVA Embolization Particles Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PVA Embolization Particles by Application
  1. 5.1 PVA Embolization Particles Market by Application
  2. 5.1.1 Trauma Embolization
  3. 5.1.2 Liver Tumor Embolization
  4. 5.1.3 Prostatic Artery Embolization
  5. 5.1.4 Uterine Fibroid Embolization
  6. 5.1.5 Other
  7. 5.2 Global PVA Embolization Particles Market Size by Application
  8. 5.2.1 Global PVA Embolization Particles Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global PVA Embolization Particles Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global PVA Embolization Particles Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America PVA Embolization Particles Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe PVA Embolization Particles Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific PVA Embolization Particles Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America PVA Embolization Particles Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa PVA Embolization Particles Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boston Scientific Corporation
  2. 6.1.1 Boston Scientific Corporation Company Information
  3. 6.1.2 Boston Scientific Corporation Business Overview
  4. 6.1.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boston Scientific Corporation PVA Embolization Particles Product Portfolio
  6. 6.1.5 Boston Scientific Corporation Recent Developments
  7. 6.2 Terumo Corporation
  8. 6.2.1 Terumo Corporation Company Information
  9. 6.2.2 Terumo Corporation Business Overview
  10. 6.2.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Terumo Corporation PVA Embolization Particles Product Portfolio
  12. 6.2.5 Terumo Corporation Recent Developments
  13. 6.3 Sirtex Medical
  14. 6.3.1 Sirtex Medical Company Information
  15. 6.3.2 Sirtex Medical Business Overview
  16. 6.3.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sirtex Medical PVA Embolization Particles Product Portfolio
  18. 6.3.5 Sirtex Medical Recent Developments
  19. 6.4 Merit Medical
  20. 6.4.1 Merit Medical Company Information
  21. 6.4.2 Merit Medical Business Overview
  22. 6.4.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merit Medical PVA Embolization Particles Product Portfolio
  24. 6.4.5 Merit Medical Recent Developments
  25. 6.5 INterface BIOmaterials
  26. 6.5.1 INterface BIOmaterials Company Information
  27. 6.5.2 INterface BIOmaterials Business Overview
  28. 6.5.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 INterface BIOmaterials PVA Embolization Particles Product Portfolio
  30. 6.5.5 INterface BIOmaterials Recent Developments
  31. 6.6 HENGRUI Medical
  32. 6.6.1 HENGRUI Medical Company Information
  33. 6.6.2 HENGRUI Medical Business Overview
  34. 6.6.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HENGRUI Medical PVA Embolization Particles Product Portfolio
  36. 6.6.5 HENGRUI Medical Recent Developments
  37. 6.7 Cook Medical
  38. 6.7.1 Cook Medical Company Information
  39. 6.7.2 Cook Medical Business Overview
  40. 6.7.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cook Medical PVA Embolization Particles Product Portfolio
  42. 6.7.5 Cook Medical Recent Developments
  43. 6.8 BTG Medical
  44. 6.8.1 BTG Medical Company Information
  45. 6.8.2 BTG Medical Business Overview
  46. 6.8.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BTG Medical PVA Embolization Particles Product Portfolio
  48. 6.8.5 BTG Medical Recent Developments
  49. 6.9 Alicon
  50. 6.9.1 Alicon Company Information
  51. 6.9.2 Alicon Business Overview
  52. 6.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alicon PVA Embolization Particles Product Portfolio
  54. 6.9.5 Alicon Recent Developments
7 North America by Country
  1. 7.1 North America PVA Embolization Particles Sales by Country
  2. 7.1.1 North America PVA Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PVA Embolization Particles Sales by Country (2021-2026)
  4. 7.1.3 North America PVA Embolization Particles Sales Forecast by Country (2027-2032)
  5. 7.2 North America PVA Embolization Particles Market Size by Country
  6. 7.2.1 North America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PVA Embolization Particles Market Size by Country (2021-2026)
  8. 7.2.3 North America PVA Embolization Particles Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PVA Embolization Particles Sales by Country
  2. 8.1.1 Europe PVA Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PVA Embolization Particles Sales by Country (2021-2026)
  4. 8.1.3 Europe PVA Embolization Particles Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PVA Embolization Particles Market Size by Country
  6. 8.2.1 Europe PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PVA Embolization Particles Market Size by Country (2021-2026)
  8. 8.2.3 Europe PVA Embolization Particles Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PVA Embolization Particles Sales by Country
  2. 9.1.1 Asia-Pacific PVA Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PVA Embolization Particles Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PVA Embolization Particles Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PVA Embolization Particles Market Size by Country
  6. 9.2.1 Asia-Pacific PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PVA Embolization Particles Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PVA Embolization Particles Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PVA Embolization Particles Sales by Country
  2. 10.1.1 South America PVA Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PVA Embolization Particles Sales by Country (2021-2026)
  4. 10.1.3 South America PVA Embolization Particles Sales Forecast by Country (2027-2032)
  5. 10.2 South America PVA Embolization Particles Market Size by Country
  6. 10.2.1 South America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PVA Embolization Particles Market Size by Country (2021-2026)
  8. 10.2.3 South America PVA Embolization Particles Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PVA Embolization Particles Sales by Country
  2. 11.1.1 Middle East and Africa PVA Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PVA Embolization Particles Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PVA Embolization Particles Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PVA Embolization Particles Market Size by Country
  6. 11.2.1 Middle East and Africa PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PVA Embolization Particles Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PVA Embolization Particles Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PVA Embolization Particles Value Chain Analysis
  2. 12.1.1 PVA Embolization Particles Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PVA Embolization Particles Production Mode & Process
  7. 12.2 PVA Embolization Particles Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PVA Embolization Particles Distributors
  10. 12.2.3 PVA Embolization Particles Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst